Thermo Fisher Scientific | TMO - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 364M 78M 2025-12
Becton, Dickinson and Co. USD 39M 354M 2026-03
Bio Techne USD 50.78M 34.21M 2025-12
Bio-Rad Laboratories USD 542.1M 1.23B 2026-06
Boston Scientific USD 1.42B 261M 2026-06
Bruker USD 117M 95.1M 2026-06
Charles River Laboratories USD -29.94M 264.16M 2026-03
Danaher USD 1.08B 157M 2026-06
Dentsply International USD -42M 105M 2026-03
Edwards Lifesciences USD 529.3M 90.4M 2026-06
General Electric Aerospace USD 2.2B 654M 2026-03
Henry Schein USD 137M 13M 2026-06
Illumina USD 260M 103M 2026-06
Intuitive Surgical USD 940.4M 15.2M 2026-03
IQVIA Holdings USD 301M 5.92B 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Medtronic USD 2.45B 1.04B 2026-03
Mettler Toledo International USD 209.66M 119.42M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
Olympus JPY 27.56B 484M 2026-06
OraSure Technologies USD -18.43M 5.14M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Repligen USD 14.15M 12.38M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Stryker USD 850M 855M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Veracyte USD 26.52M 3.45M 2026-06
Waters USD 356M 444M 2026-06
Zimmer Biomet Holdings USD 487.5M 186.2M 2026-06